The IPKat

The emergence of “relevant ranges” and retroactive insufficiency in Australia and the UK

Never Too Late: If you missed the IPKat last week!

Bloody good outcome for Impossible Foods as EPO Board of Appeal revives patent for vegan meat substitute (T 0425/23)

Fishy evidence: Do we have the right sufficiency standard for therapeutic use? (T 1057/22)

Chocolate teapots and nuclear bombs: Whole range sufficiency of mechanical inventions (T 0149/21)

Abrasive outcome on over-broad ranges for 3M in Saint-Gobain dispute re-emphasizes importance of narrow dependent claims

When does pre-clinical data plausibly support a therapeutic effect? (T 966/18)

Never Too Late: if you missed The IPKat last week

Illumina v MGI Part 1: Mr Justice Birss on sufficiency, DNA sequencing and chocolate teapots

Canadian Federal Court considers whether Teva's COPAXONE second medical use patents were obvious-to-try (Teva v Pharmascience)